Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UDIs And Adverse Events Draw Attention In Electronic Record Meaningful Use Comments

This article was originally published in The Gray Sheet

Executive Summary

Organizations such as Pew and the American College of Cardiology focused on the potential of electronic health records to employ unique device identifiers and report adverse events.

You may also be interested in...



FDA Issues UDI Final Rule, Removes Direct Marking Requirement For Implants

The long-awaited unique device identifier final rule is intended to help FDA, device companies and health care providers track medical devices. The rule addresses many of industry’s concerns with FDA’s initial proposal and was met with general support by companies.

FDA Reconsiders UDI Direct Marking Requirements For Implants

An agency official says FDA is reworking the UDI direct part marking requirements for implants and making other changes in the final unique device identification rule, due out in June.

Digital Health In Brief

Asthmapolis gets new funding; Rock Health releases Q1 funding numbers; Cochrane Collaboration examines digital diabetes self-management systems.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032270

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel